January 27, 2025
In the News
January 16, 2025
Cell & Gene The Podcast: The Future of NK Cell Therapy for Autoimmune Disease
November 18, 2024
PharmaShots: Enhancing Care with NK Cell Therapy
November 4, 2024
BioProcess Insider: Artiva Discusses Scalable NK Cells to Treat Autoimmune Diseases
August 16, 2024
BiotechTV: Checking in with Artiva CEO Fred Aslan after the Company’s $167 Million IPO
May 30, 2024
Pharmaphorum Podcast: Move over CAR-T – the Potential of NK Cells in Cell Therapy
April 24, 2024
Cell & Gene: NK Cell Therapies – How Artiva Biotherapeutics Leverages Its “Manufacturing First” Approach
March 1, 2024
BiotechTV: Using NK Cell Therapies for Autoimmune Disease and Cancer with Artiva’s CEO
March 1, 2024
Clinical Trials Arena: Artiva Prepares to Kick off Phase I/II Trial for NK Cell Therapy
February 21, 2024